Amend Surgical
ApprovedAmend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFUSE and Amend Tissue Tape, and other medical devices.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $38.5M
About
Amend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFUSE and Amend Tissue Tape, and other medical devices.
Medical DevicesRegenerative Medicine
Funding History
4Total raised:$38.5M
Series A$15MNov 15, 2022
Series A$15MSep 15, 2022
Seed$5MJun 15, 2021
Seed$3.5MMay 15, 2021